Drug · DIN 02343169
SIMVASTATIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 25, 2014; first marketed June 11, 2010.
- Drug Identification Number (DIN)
- 02343169
- Company (DIN owner)
- Meliapharm IncMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Simvastatin C10AA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SIMVASTATIN | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 5, 2010: NOC 11016Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named SIMVASTATIN
- DIN 02284723 · Marketed
- DIN 02284731 · Marketed
- DIN 02284758 · Marketed
- DIN 02284766 · Marketed
- DIN 02284774 · Marketed
- DIN 02386291 · Marketed
- DIN 02386305 · Marketed
- DIN 02386313 · Marketed
- DIN 02386321 · Marketed
- DIN 02386348 · Marketed
- DIN 02342456 · Cancelled Pre Market
- DIN 02342464 · Cancelled Pre Market
- DIN 02342472 · Cancelled Pre Market
- DIN 02342480 · Cancelled Pre Market
- DIN 02342499 · Cancelled Pre Market
- DIN 02343142 · Cancelled Post Market
- DIN 02343150 · Cancelled Post Market
- DIN 02343177 · Cancelled Post Market
- DIN 02343185 · Cancelled Post Market
- DIN 02379503 · Cancelled Pre Market